According to this new report, the global cardiac biomarkers testing market is estimated to be valued at US$ 5.7 billion in the year 2028, growing at a CAGR of 8.5% in the period 2020 to 2028. Growth ...

The following is a summary of “Evaluation of severe rhabdomyolysis on day 30 mortality in trauma patients admitted to ...

ALSO READ: Vigorous exercise not linked to increased risk of adverse cardiac events in long QT syndrome: Study During the ...